Skip to main content
3160 Results
 
msf-placeholder
Tuberculosis

Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis

The World Health Organization recommended two new drugs, bedaquiline (BDQ) and delamanid (DLM), for the treatment of multidrug-resistant tuberculosis (MDR-TB) in 2013 and 2014, respectively. An estimated one third of patients with MDR-TB would benefit from the inclusion of these drugs in their treatment regimens. The International Journal of Tuberculosis and Lung Disease - 1 Apr 2018
 
msf-placeholder
Tuberculosis

Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?

Visceral leishmaniasis (VL)-human immunodeficiency virus (HIV) coinfection remains a major problem in Ethiopia, India, and Brazil. Tuberculosis (TB), a treatable factor, could contribute to high mortality (up to 25%) in VL-HIV coinfection. However, the current evidence on the prevalence and clinical impact of TB in VL-HIV coinfection is very limited. In previous reports on routine care, TB prevalence ranged from 5.7% to 29.7%, but information on how and when TB was diagnosed was lacking.
Open Forum Infectious Diseases - 1 Apr 2018
 
Fighting in Ituri province
Democratic Republic of Congo

Stories of flight across Lake Albert

“It’s different this time. In the 2000s our homes were torched too, but we were able to go back to our villages. Now people are being hunted down and killed." Project Update - 23 Mar 2018
 
msf-placeholder
Tuberculosis

Tackling mortality due to childhood tuberculosis

The Lancet - 23 Mar 2018
 
TB programs in Gulf Province and Port Moresby
Papua New Guinea

Bringing TB treatment closer to home

An estimated 30,000 new cases in 2016, expanding and improving TB care in PNG is an uphill battle. Project Update - 23 Mar 2018
 
Insein clinic, for treatment for HIV, TB, and Hepatitis C in Yangon. By Alessandro Penso, Feb 2018.
Tuberculosis

“An obvious, urgent focus for MSF”

Dr. Francis Varaine, leader of the MSF working group on Tuberculosis, explains MSF’s priorities over the next 10 years. Voices from the Field - 22 Mar 2018
 
Rohingya New arrivals
Rohingya refugee crisis

“We don’t have anywhere else to go”

Having fled indescribable violence in Myanmar, Rohingya refugees in Bangladesh must now contend with new dangers: precarious living conditions, the upcoming rainy season and fears for personal safety after dark. Voices from the Field - 15 Mar 2018
 
Maternal and Child Health services in Douentza Hospital .
Mali

Medical services in northeastern Mali

Photo Story - 13 Mar 2018
 
Rohingya refugees in Bangladesh
Rohingya refugee crisis

‘No one was left’ - Death and Violence Against the Rohingya

MSF releases new advocacy report which explains 2017 Rohingya violence survey findings
Report - 9 Mar 2018
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more